Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

AIDS

Volumn 11, Issue 8, 1997, Pages 1013-1021

  Fowke, Keith R ^c   D'Amico, Ronald ^a   Chernoff, David N ^b   Pottage Jr , John C ^a   Benson, Constance A ^a   Sha, Beverly E ^a   Kessler, Harold A ^a   Landay, Alan L ^a   Shearer, Gene M ^c  

^a RUSH MEDICAL COLLEGE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; HIV; Immunization; Influenza; T cell response; Viral load

Indexed keywords

CD4 ANTIGEN; INFLUENZA VACCINE; LAMIVUDINE; NUCLEOSIDE ANALOG; SAQUINAVIR; VIRUS ANTIBODY; VIRUS RNA; ZIDOVUDINE;

APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL DEATH; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VACCINATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, VIRAL; APOPTOSIS; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; RNA, VIRAL; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION;

EID: 0030959374     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199708000-00010     Document Type: Article

References (31)

1. Prevention and control of influenza recommendations of the immunization practices advisory committee (ACIP). MMWR 1995, 44:1-22.
2. Prevention and control of influenza-part I, vaccines: Recommendation of the Advisory Committee on Immunization Practices. MMWR 1993, 42:1-14.
3. Jones KA, Kadonaga JT, Luciw PA, Tjan R: Activation of the AIDS retrovirus promoter by the cellular transcription factor. Science 1986, 232:755-759.
4. Garcia JA, Wu FK, Mitsuyasu R, Gaynor RB: Interaction of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J 1987, 6:3761-3770.
5. Zack JA, Arrigo SJ, Weitsman SR, et al.: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.
6. Stevenson M, Stanwick IL, Dempsey MP, Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990, 9:1551-1560.
7. Bukrinsky ML, Stanwick TL, Sempsey MP, Stevenson M: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991, 254:423-427.
8. Schnittman SM, Fauci AS: Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv Intern Med 1994, 39:305-355.
9. Laurent-Crawford AF, Krust JB Muller S, et al.: Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses 1993, 9:761-773.
10. Luosto L, Montani MSG, Lorenzetti S, et al.: Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations. Eur J Immunol 1995, 25:2907-2916.
11. Corbeil J, Richman DD: Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. J Gen Virol 1995, 76:681-690.
12. Finkel TH, Tudor-Williams G, Banda NK, et al.: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV- infected lymph nodes. Nature Med 1995, 1:129-134.
13. Sabbaj S, Para MF, Fass RJ, et al.: Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol 1992, 12:216-224.
14. Clerici M, Sarin A, Berzofsky JA, et al.: Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996, 10:603-611.
15. Clerici M, Stocks NI, Zajac RA, et al.: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals Nature 1989, 339:383-385.
16. Sarin A, Clerici M, Blatt SP, et al.: Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 1994, 153:862-872.
17. Clerici M, Sarin A, Coffman RL, et al.: Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994, 91:11811-11815.
18. Clerici M, Stocks NI, Zajac RA, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989; 84:1892-1899.
19. Washington JA (Ed.): Laboratory Procedures in Clinical Microbiology, 2nd edn. New York: Springer-Verlag; 1985:125-137.
20. Kern D, Collins M, Fultz T, et al.: An enhanced sensitivity branched DNA (ES bDNA) assay for the quantification of HIV-1 RNA in plasma. J Clin Micro 1996, 34:3196-3202.
21. Pachl C, J Todd, D Kerns, et al.: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA (bDNA) signal amplification assay. J Acquir Immune Defic Syndr 1995, 8:446-454.
22. Staprans SI, Hamilton BL, Follansbee SE, et al.: Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995, 182:1727-1737.
23. O'Brien WA, Grovit-Ferbas K, Namazi A, et al.: Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995, 86:1082-1089.
24. Yerly S, Wunderli W, Wyler CA, et al.: Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load [letter]. AIDS 1994, 8:1503-1504.
25. Stanley SK, Ostrowski MA, Justement JS, et al.: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996, 334:1222-1230.
26. Rosok B, Voltersvik P, Bjerkenes K, et al.: Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 1996, 104:203-207.
27. Jackson CR, Vavro CL, Pennington KN, et al.: Effect of influenza immunization on immunologic and virologic parameters in HIV+ pediatric patients. Third Conference on Retrovirus and Opportunistic Infections. Washington, DC, January February 1996 [abstract 424].
28. Mercure L, Lalonde R, Phaneuf D, Brenner B, Wainberg MA: Inhibitory effect of 3′-azido-3′- deoxythymidine on proliferative responsiveness of CD8+ lymphocytes to interleukin-2. Clin Diagn Lab Immunol 1994, 1:482-485.
29. Poland G, Love K, Hughes C: Routine immunization of the HIV-positive asymptomatic patient. J Gen Intern Med 1990, 5:147-152.
30. Nelson K, Clements M, Miotti P, Cohn S, Polk H: The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza virus. Ann Intern Med 1988, 109:383-388.
31. Kroon FP, van Dissel JT, de Jong JC, van Furth R: Antibody responses to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994, 8:469-476.